A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382

α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594

Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,520

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J. D. M., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,469

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316

Identification of two distinct synucleins from human brain

Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080

Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies

Spillantini, M. G., Crowther, R. A., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,052

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch

George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844

Protein Recognition of Linear and Cyclic Peptides of Homologous Sequences Implicated in the Aggregation of α-Synuclein

Martins, G. F., Rocha, C., & Galamba, N. (2025) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5c05501 · Cited by 1

Familial mutations modulate α‐synuclein interactions with key neuronal membrane lipids

Ali, A., Matveyenka, M., & Kurouski, D. (2025) · FEBS Journal · doi:10.1111/febs.70363 · Cited by 1

Inertial Agitation in an NMR Magnet: Real-Time Monitoring of Protein Aggregation at High Resolution

Lee, J., Jung, S., Yu, S., Park, S. H., Kim, N., & Lee, J. H. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c16918 · Cited by 1

Effect of sequence variations on the phase behavior of a functional IDP fragment

Chakraborty, S., Mishra, N., & Biswas, M. (2026) · The Journal of Chemical Physics · doi:10.1063/5.0299964 · Cited by 1

α-Synuclein Deletion Leads to Hyposmia: due to Defective Autophagy Induced by Abnormal PI3K/mTOR Signaling Pathway in Olfactory Bulb

Shi, Y., Wang, H., Chen, J., Ren, J., Sun, X., Qu, M., Zhao, T., Han, C., Yuan, J., Meng, F., et al. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05686-2 · Cited by 1

Accelerated and localized synucleinopathy in a hybrid mouse model: implications for positron emission tomography studies

Xia, C. A., Tsai, H., Garcia, S. D., Liu, S., Matzeu, A., Salarian, M., Bruinzeel, W., & Szardenings, A. K. (2026) · npj Imaging · doi:10.1038/s44303-026-00138-x · Cited by 1

Multiscale Insights into the Ionic‐Strength Dependence of α‐Synuclein Liquid–Liquid Phase Separation

Chen, C., Yan, Z., Ma, Y., & Ding, H. (2026) · Macromolecular Rapid Communications · doi:10.1002/marc.202500966 · Cited by 1

Beyond Amyloids: Neuroprotective Potential of Betanin and its Derivatives Against Alpha-Synuclein Aggregates and ROS Overload in Parkinson’s Disease

Ghahari, A., Alikhanian, A., Solaei, F. A., Fattahi, A., Hourfar, H., Schallmey, A., Mohammadi, M., & Morshedi, D. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-026-02534-9 · Cited by 1

Early α-synuclein–mediated mitochondrial dysfunction in a human cell model of Parkinson’s disease dementia

Alfaidi, M., Wenger, L. M. D., Szebényi, K., Stoker, T. B., He, X., Fazal, S. V., Šebestíková, J., Jassim, A., Gilbertson, R. J., Garza, R., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10134-x · Cited by 1

Structural biology of alpha-synuclein amyloid filaments: Implications in synucleinopathies

Gonçalves, P. D. C., Fernández, I., & Fernández, C. O. (2026) · Journal of Parkinson s Disease · doi:10.1177/1877718x261461375 · Cited by 1

Phase separation and protein aggregation in neurodegenerative diseases

Seiglière, H. D. L., Letourneur, Æ., Ichas, F., & Giorgi, F. D. (2026) · Biophysical Chemistry · doi:10.1016/j.bpc.2026.107678 · Cited by 1

Neuroprotective and Neurotoxic Properties of α-Synuclein in Cell Culture Models of Dopaminergic Degeneration

Sun, F., Anantharam, V., Jin, H., Zhang, D., Kanthasamy, A., & Kanthasamy, A. G. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00036-1 · Cited by 1

Pathogenesis of neurodegenerative diseases via templated recruitment

Guo, J. (2013) · ScholarlyCommons (University of Pennsylvania) · Cited by 1

Alpha-Synuclein Interactions with Membranes

Pirc, K., & Poklar, N. (2011) · InTech eBooks · doi:10.5772/16816 · Cited by 1

Amyloid Polymorphism of α-Synuclein Induced by Active Firefly Luciferase

Yang, J. E., Hong, J. W., Kim, J., & Paik, S. R. (2014) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2014.35.2.425 · Cited by 1

Protein seeding in Alzheimer’s disease and Parkinson’s disease: Similarities and differences

Ibrahim, T. (2014) · World Journal of Neurology · doi:10.5316/wjn.v4.i4.23 · Cited by 1

Invisible Killers

Volpicelli‐Daley, L. A., & Standaert, D. G. (2016) · Movement Disorders · doi:10.1002/mds.26465 · Cited by 1

Large Unilamellar Vesicles of Phosphatidic Acid Reduce the Toxicity of α-Synuclein Fibrils

Ali, A., Holman, A. P., Rodriguez, A., Zhaliazka, K., Osborne, L., & Kurouski, D. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01012 · Cited by 1

Alpha-synuclein as a Molecular Marker for the Diagnosis of Neurological Disorders

Bagree, G., Silva, O. D., Liyanage, P. D., Mahasivam, S., Bansal, V., & Ramanathan, R. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837673216-00286 · Cited by 1

Therapeutic Strategies in Neurodegenerative Diseases

Eid, A. M., Faridar, A., & Appel, S. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_39 · Cited by 1

CFS Biomarkers in Parkinson’s Disease

Parnetti, L., Castrioto, A., De, C., Chiasserini, D., Tambasco, N., Rossi, A., Balducci, C., Beccari, T., & Calabresi, P. (2011) · InTech eBooks · doi:10.5772/16666 · Cited by 1

Amyloidogenic Protein of α-Synuclein

Yang, J. E., & Paik, S. R. (2013) · Hanyang Medical Reviews · doi:10.7599/hmr.2013.33.2.123 · Cited by 1

Topographical Propagation of α-synuclein Pathology in Parkinson's Disease: Phenomenology and Hypothetical Mechanism

Hyun, M., & Lee, S. (2009) · Experimental Neurobiology · doi:10.5607/en.2009.18.1.19 · Cited by 1

Molecular Biology of Dementia with Lewy Bodies

Hasegawa, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55948-1_4 · Cited by 1

Amyloidogenic Pattern Prediction of HIV-1 Proteins

Sneha, P., Balaji, S., & Shapshak, P. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7290-6_33 · Cited by 1

Insights into the misfolding of ‒synuclein in the presence of metal ions: a simulation study

Pagadala, N. S. (2018) · MOJ Drug Design Development & Therapy · doi:10.15406/mojddt.2018.02.00030 · Cited by 1

Biomarker detection of Parkinson’s disease: therapy and treatment using nanomaterials

Nanda, R., Panda, P., & Mishra, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817923-9.00017-1 · Cited by 1

Engineering of a protein probe with multiple inputs and multiple outputs for evaluation of alpha synuclein aggregation states

Chau, E., & Kim, J. R. (2021) · Biochemical Engineering Journal · doi:10.1016/j.bej.2021.108292 · Cited by 1

The Stimulatory Effects of Intracellular α-Synuclein on Synaptic Transmission Are Attenuated by 2-Octahydroisoquinolin-2(1H)-ylethanamine

Muñoz, A. R., Fernández-Pérez, E. J., Olivos, N., Burgos, C. F., Boopathi, S., Armijo‐Weingart, L., Pacheco, C. R., González, W., & Aguayo, L. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413253 · Cited by 1

Structural and Functional Insights into α‐Synuclein–Lipid Interactions

Stöckl, M. T., van Rooijen, B. D., Claessens, M. M. A. E., & Subramaniam, V. (2011) · Wiley eBooks · doi:10.1002/9783527634323.ch2 · Cited by 1

The interplay between Lewy body-like alpha-synuclein aggregates and protein degradation pathways in a cell-based model of Parkinson's disease

Tanik, S. A. (2013) · Scholarly Commons (University of Pennsylvania) · Cited by 1

Oligomerization, Degradation and Aggregation Reactions and Products of Synuclein Polypeptides Related to Parkinson’s Disease

Vlad, C. (2011) · KOPS (University of Konstanz) · Cited by 1

Biophysical characterization of alpha-synuclein aggregates : Parkinson's disease at the nanoscale

van Raaij, M. E. (2008) · doi:10.3990/1.9789036527477 · Cited by 1

Neurodegenerative α-Synucleinopathies

Goedert, M., & Spillantini, M. G. (2005) · Humana Press eBooks · doi:10.1385/1-59259-834-x:077 · Cited by 1

Alpha-synuclein and the multiple hit hypothesis of Parkinson's disease

Feng, L. (2012) · DigitalGeorgetown (Georgetown University Library) · Cited by 1

CIBLAGE ASTROCYTAIRE DE L'EXPRESSION DU GDNF PAR DES LENTIVECTEURS POUR UNE THERAPIE GENIQUE DE PROTECTION DE LA MALADIE DE PARKINSONPreprint

Mammeri, H. (2006) · Cited by 1

The use of cell-free systems to characterize parkinson's disease-related gene products

Rochet, J., & Schieler, J. L. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00043-9 · Cited by 1

BIOPHYSICAL STUDIES OF THE ALPHA-SYNUCLEIN PROTEIN ASSOCIATED WITH PARKINSON’S DISEASE AND OTHER SYNUCLEINOPATHIES

Apetri, M. M. (2006) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1

Aggregation and conformation of alpha-synuclein: effects of ligand binding and phosphomimetics

Paskins, A. R. (2017) · Sheffield Hallam University · doi:10.7190/shu-thesis-00071 · Cited by 1

Conformational changes and the self-assembly of alpha-synuclein

Mason, R. J. A. (2018) · Sheffield Hallam University · doi:10.7190/shu-thesis-00151 · Cited by 1

Exceptional aggregation propensity of amino acids in polyglutamine amino-acid-homopolymerPreprint

Mishra, R., & Thakur, A. K. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.09.194753 · Cited by 1

Physiological α-synuclein S129 phosphorylation mediates postsynaptic and nuclear interactions in the human brainPreprint

Choi, S. G., Duvernay, J. B., Bahrami, A., Tittle, T., Sani, S., Kordower, J. H., Muller, S., & Killinger, B. A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.22.649861 · Cited by 2

Cortical α-synuclein pathology induces neuronal hypoactivity and circuit changes but not functional impairments in a model of early Lewy body dementia

Theint, A. T., Cazares, N., Zhang, S., Zhang, N., Mosley, R., Ishida, K., Higuchi, M., Peng, C., & Zeiger, W. (2026) · npj Parkinson s Disease · doi:10.1101/2025.07.31.668024 · Cited by 1

Effets des mutations sur la structure et la dimérisation de l'alpha-synucléine et implications pour la maladie de Parkinson : réponses apportées par la dynamique moléculaire à gros grains

Guzzo, A. (2022) · theses.fr (ABES) · doi:10.70675/0849285az2731z415cza277z0e56728f62bc · Cited by 1

α-Synuclein, CSPα, SNAREs and Neuroprotection in vivo

Chandra, S. S., & Südhof, T. C. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00022-1

Molecular Biology of α-Synuclein

Rieß, O., Krüger, R., Kobayashi, H., Holzmann, C., Hattori, N., & Mizuno, Y. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_85

Modeling Disease-Related Proteins in Saccharomyces cerevisiae: Insights into Alpha-Synuclein and TorsinA Biology

Valastyan, J. S. (2013) · DSpace@MIT (Massachusetts Institute of Technology)

Regional lysosomal malfunction underlies the selectivity of alpha-synuclein neurodegeneration

Malkus, K. A. (2011) · Scholarly Commons (University of Pennsylvania)

Effects of Aggregated Alpha-Synuclein on Cultured Neuronal Cells

Freeman, D. W. (2015) · Loyola eCommons (Loyola University of Chicago)

Synucleins in the midbrain dopaminergic system : the role in health and disease

Connor‐Robson, N. (2013) · ORCA Online Research @Cardiff (Cardiff University)

The role of alpha synuclein in Parkinson’s disease

Moualla, D. (2011) · The University of Bath Online Publications Store (The University of Bath)

Behavioural analysis of transgenic mice overexpressing gamma-synuclein

Salem, H. (2011) · ORCA Online Research @Cardiff (Cardiff University)

Treating Oxidative Neural Injury: Methionine Sulfoxide Reductase Therapy for Parkinson’s Disease

Wassef, R., Heinemann, S. H., & Hoshi, T. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_12

Insight into Familial and Sporadic Parkinson’s Disease: α-Synuclein Mutant Analysis in a Fission Yeast Model

Valtierra, S. (2009) · Eukaryon

Parkinson’s Disease Associated Protein α-Synuclein-E46K Demonstrates Strain and Ploidy-Specific Toxicity in Budding Yeast

White, M. (2008) · Eukaryon

The Effects of Prolyl Oligopeptidase Inhibition in α-Synuclein Based Mouse Models of Parkinson's Disease

Savolainen, M. H. (2015) · Työväentutkimus Vuosikirja

Utilizing Galectin 3 as a Marker of Ruptured Vesicles In Vivo

London, J. (2015) · Loyola eCommons (Loyola University of Chicago)

Role of Aberrant α-Synuclein–Membrane Interactions in Parkinson’s Disease

Griggs, A. M., Ysselstein, D., & Rochet, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00039-0

Non-Canonical Amino Acids as Minimal Tags for Investigating Protein Organization and Turnover

Gebura-Vreja, I.-C. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5450

Détection et caractérisation de peptides obliques au sein des protéines amyloïdogéniques

Crowet, J., Brasseur, R., & Lins, L. (2008)

Les marqueurs biologiques de l'atrophie multisystématisée

Laurens, B. (2014) · HAL

The role of alpha-synuclein phosphorylation in synucleinopathies

Basso, E. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Extracellular vesicle release of α-Synuclein is mediated by SUMOylation

Kunadt, M. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5371

Amyloid State of Proteins in Human Disease

Huang, L., & Huang, K. (2015) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0024459

MODULATION OF ALPHA-SYNUCLEIN PROTEIN FOLDING BY A MARINE-SOURCED EXTRACT

Giffin, J. C., Richards, R. C., Craft, C., Jahan, N., Chopin, T., Szemerda, M., MacKinnon, S. L., & Ewart, K. V. (2013) · DalSpace (Dalhousie University)

Etude expérimentale du peptide oblique de l'α-synucléine

Gembloux, A. D. (2004)

Investigating the effects of α-synuclein variants on mitochondrial function in Parkinson's disease

Yates, R. A. (2015)

COMMUNAUTE FRANÇAISE DE BELGIQUE ACADEMIE UNIVERSITAIRE WALLONIE-EUROPE FACULTE UNIVERSITAIRE DES SCIENCES AGRONOMIQUES DE GEMBLOUX Détection et caractérisation de peptides obliques au sein de protéines amyloïdogéniques

Crowet, J. (2008)

pH- and temperature-dependent mechanisms of non-native aggregation of anti-CD40 IgG1

Wu, H. (2024) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/83s2-4831

The Neuroprotective Role of Micronutrients in Parkinson’s Disease

Malkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · doi:10.1201/9781420073522-7

The design, characterization and utility of self-assembling hydrophobic collagen peptides

McGuinness, K. N. (2016) · doi:10.7282/t3k076b0

Basic algorithms of bioinformatics

King, M. R., & Mody, N. A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511780936.010

Nanoelectrode Arrays for Monitoring and Modulating Nervous System Electrical and Chemical Activity

(2012) · CRC Press eBooks · doi:10.1201/b11835-10

Characterization of hypertonic stress-induced protein damage and the cellular mechanisms for defense and repair in C. elegans

Burkewitz, K. (2012)

Pathogenic mechanisms in multiple system atrophy: a study of oligodendroglial pathology

Asi, Y. T. (2014) · UCL Discovery (University College London)

Domain-specific differences between alpha- and beta-synuclein serve as a threshold for fibril formation in combination with changes in environmental conditions

Olson, M. P. (2016) · doi:10.7282/t3154kb5

Synuclein misfolding as a therapeutic target

Peelaerts, W., & Outeiro, T. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00002-6

PARK1 and α-Synuclein

Langston, J. W., Golbe, L. I., & Lee, S. (2003) · Elsevier eBooks · doi:10.1016/b978-012566652-7/50029-0

Design of novel inhibitors targeting the mutated protein of alpha synuclein using computational approach

Panda, S., & Guttula, P. K. (2017) · International Journal of Pharma and Bio Sciences · doi:10.22376/ijpbs.2017.8.4.b330-337

Approach Towards The Development Of Novel Disease Modifying Therapeutics For Parkinson's Disease

Luo, D. (2017) · Human Biology

Modification of α-Synuclein by Phosphorylation: A Pivotal Event in the Cellular Pathogenesis of Parkinson’s Disease

Datta, I., & Ganapathy, K. (2017) · InTech eBooks · doi:10.5772/intechopen.70405

Interactions of the disordered TPPP/p25 with physiological and pathological partners

Szunyogh, S. (2017) · Eötvös Loránd Tudományegyetem · doi:10.15476/elte.2016.188

Design of antioxidant nanotherapeutics for attenuation of atherogenesis and neuroinflammation

Chmielowski, R. (2018) · doi:10.7282/t32n55gh

Analysis of the mechanisms of interaction of alpha-synuclein and membranes in cellular models of Parkinson´s Disease

Masaracchia, C. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7134

The Propagation of Neurodegenerative Diseases by Inflammation and Exosomes

Sackmann, V. (2019) · Linköping University medical dissertations · doi:10.3384/diss.diva-160949 · Cited by 1

The structure of the native α-synuclein ensemble determined using a combination of structural proteomics and discrete molecular dynamics simulations

Brodie, N. I. (2020) · Journal of Proteomics

Recapitulating Parkinson’s disease pathology in a three-dimensional neural cell culture model

Taylor-Whiteley, T. R. (2019) · Sheffield Hallam University · doi:10.7190/shu-thesis-00321

CSF Biomarkers in Parkinson's disease

Parnetti, L., Castrioto, A., Carlo, C. D., Chiasserini, D., Tambasco, N., Rossi, A., Michiara, M., Beccari, T., & Calabresi, P. (2011)

Mecanismes de toxicitat de la dopamina en cèl·lules de neuroblastoma humà SH-SY5Y

Xavier, P. G. (2008) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)

Misfolded Proteins

Merino, P. (2019) · Wiley eBooks · doi:10.1002/9783527813421.ch9

The Neuroprotective Role of Micronutrients in Parkinson’s Disease

Tsika, E., Ischiropoulos, H., & Malkus, K. A. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch2

Faculty Opinions recommendation of Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies.

Fasano, A. A., & Breen, D. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733203098.793545981

Faculty Opinions recommendation of Cryo-EM structure of alpha-synuclein fibrils.

Scheres, S. H. W. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733570511.793550310

The role of RNA in synapse physiology and neurodegeneration in models of Parkinson´s disease

Xylaki, M. (2021) · doi:10.53846/goediss-9275

The Effects of Stress on Lewy Pathology in Dopamine NeuronsPreprint

Zhang, X., Zhao, M., zhang, L., Geng, D., Huang, M., Li, D., gao, Y., Zhang, F., Zhan, C., Yuan, K., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4098912

Dissolution of amyloid aggregates by direct addition of alkali halides

Takekiyo, T., Yamada, N., Amo, T., Nakazawa, C. T., Asano, A., Ichimura, T., Katō, M., & Yoshimura, Y. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.120849

Caracterização da Hsp90 de Aedes aegypti e seus interatores SGT e complexo R2TP

Quel, N. G. (2019) · doi:10.47749/t/unicamp.2019.1233092

Computational investigation on the conformational dynamics of C-terminal truncated α-synuclein bound to membrane

Das, D., & Mattaparthi, V. S. K. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2310788

Characterization of the molecular interaction between α-synuclein and prion protein

Domingues, R. (2024) · doi:10.53846/goediss-10323

Comparative protein structural analyses of α-synuclein linked pathogenic variants reveal the role of N-terminally located critical region in Parkinson’s disease pathogenesis

Mughal, K. A., Khan, A. Q., Sarwar, A., Mahmood, R., & Abbasi, A. A. (2024) · Biologia · doi:10.1007/s11756-024-01713-6

Characterization of Hydrophobic Residue Requirements for α-Synuclein Fibrillization

Waxman, E. A., Mazzulli, J. R., & Giasson, B. I. (2009) · Biochemistry · doi:10.1021/bi900539p · Cited by 110

A Peptide Motif Consisting of Glycine, Alanine, and Valine Is Required for the Fibrillization and Cytotoxicity of Human α-Synuclein

Du, H., Tang, L., Luo, X., Li, H., Hu, J., Zhou, J., & Hu, H. (2003) · Biochemistry · doi:10.1021/bi034028+ · Cited by 155

Sequence determinants regulating fibrillation of human α-synuclein

Koo, H.-J., Lee, H.-J., & Im, H. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.140 · Cited by 55

Sequence Determinants for Amyloid Fibrillogenesis of Human α-Synuclein

Zibaee, S., Jakes, R., Fraser, G. M., Serpell, L. C., Crowther, R. A., & Goedert, M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.09.039 · Cited by 67

A de novo designed α-helical peptide forms amyloid fibrils which are not neurotoxic

Fezoui, Y., Hartley, D. M., Walsh, D. M., Selkoe, D. J., Osterhut, J. J., & Teplow, D. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)82568-3